Endobronchial Treatment of Carcinoid Tumors of the Lung

Abstract

Background Bronchial carcinoid tumors are known as low-grade malignancies. Surgery has been proposed as the best treatment of choice for lung carcinoids. However, less invasive treatment approaches may be considered due to low-grade malignancy potential of such tumors. The aim of this study was to review the results of endobronchial treatments of carcinoid tumors of the lung and to compare with the outcome after surgery.

Methods Initial complete tumor eradication with an endobronchial treatment was attempted for 29 patients. Diode laser or argon plasma coagulation was used during these treatments. Cryotherapy or laser treatments were applied consecutively in patients for whom there was good bronchoscopic visualization of the distal and basal tumor margins and no evidence of bronchial wall involvement. Surgery was performed in cases of atypical carcinoid and in cases of nonvisualization of the basal and distal part of the tumor.

Results Overall, 29 patients have been included (median age 58 years; range, 23–77 years). Median follow-up has been 49 months (range, 22–94 months). A total of 24 patients (69%) had typical carcinoid tumor, 5 patients (31%) had atypical carcinoid tumor. Initial endobronchial treatment provided complete tumor eradication in 21 of 29 patients (72%). Of the eight other patients (28%), two were atypical carcinoids, and underwent surgical treatment. There was no tumor-related death and no recurrence during the follow-up in both groups. There was no difference for survival or recurrence between the surgical and the endobronchial treatment group of patients (p > 0.05).

Conclusion Endobronchial treatment may be considered as safe, effective treatment for typical carcinoid tumors in the central airways. Addition of initial endobronchial treatment had no negative effect on the surgical outcome.

Keywords

carcinoid tumors - lung - endobronchial treatment

• References

• 1 Davila DG, Dunn WF, Tazelaar HD, Pairolero PC. Bronchial carcinoid tumors. Mayo Clin Proc 1993; 68 (8) 795-803
• 2 Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97 (4) 934-959
• 3 Hemminki K, Li X. Incidence trends and risk factors of carcinoid tumors: a nationwide epidemiologic study from Sweden. Cancer 2001; 92 (8) 2204-2210
• 4 Skuladottir H, Hirsch FR, Hansen HH, Olsen JH. Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark. Lung Cancer 2002; 37 (2) 127-135
• 5 Mezzetti M, Raveglia F, Panigalli T , et al. Assessment of outcomes in typical and atypical carcinoids according to latest WHO classification. Ann Thorac Surg 2003; 76 (6) 1838-1842
• 6 Travis WD, Rush W, Flieder DB , et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol 1998; 22 (8) 934-944
• 7 Rizzardi G, Marulli G, Bortolotti L, Calabrese F, Sartori F, Rea F. Sleeve resections and bronchoplastic procedures in typical central carcinoid tumours. Thorac Cardiovasc Surg 2008; 56 (1) 42-45
• 8 Brokx HA, Risse EK, Paul MA , et al. Initial bronchoscopic treatment for patients with intraluminal bronchial carcinoids. J Thorac Cardiovasc Surg 2007; 133 (4) 973-978
• 9 van Boxem TJ, Golding RP, Venmans BJ, Postmus PE, Sutedja TG. High-resolution CT in patients with intraluminal typical bronchial carcinoid tumors treated with bronchoscopic therapy. Chest 2000; 117 (1) 125-128
• 10 Bertoletti L, Elleuch R, Kaczmarek D, Jean-François R, Vergnon JM. Bronchoscopic cryotherapy treatment of isolated endoluminal typical carcinoid tumor. Chest 2006; 130 (5) 1405-1411
• 11 Deygas N, Froudarakis M, Ozenne G, Vergnon JM. Cryotherapy in early superficial bronchogenic carcinoma. Chest 2001; 120 (1) 26-31
• 12 Vergnon JM. Bronchoscopic cryotherapy. J Bronchol 1995; 2: 323-327
• 13 Díaz-Jiménez JP, Canela-Cardona M, Maestre-Alcacer J. Nd:YAG laser photoresection of low-grade malignant tumors of the tracheobronchial tree. Chest 1990; 97 (4) 920-922
• 14 Okike N, Bernatz PE, Payne WS, Woolner LB, Leonard PF. Bronchoplastic procedures in the treatment of carcinoid tumors of the tracheobronchial tree. J Thorac Cardiovasc Surg 1978; 76 (3) 281-291
• 15 Aberg T, Blöndal T, Nõu E, Malmaeus J. The choice of operation for bronchial carcinoids. Ann Thorac Surg 1981; 32 (1) 19-22
• 16 Sutedja TG, Schreurs AJ, Vanderschueren RG, Kwa B, vd Werf TS, Postmus PE. Bronchoscopic therapy in patients with intraluminal typical bronchial carcinoid. Chest 1995; 107 (2) 556-558
• 17 van Boxem TJ, Venmans BJ, van Mourik JC, Postmus PE, Sutedja TG. Bronchoscopic treatment of intraluminal typical carcinoid: a pilot study. J Thorac Cardiovasc Surg 1998; 116 (3) 402-406
• 18 McCaughan BC, Martini N, Bains MS. Bronchial carcinoids. Review of 124 cases. J Thorac Cardiovasc Surg 1985; 89 (1) 8-17
• 19 Katsenos S, Rojas-Solano J, Schuhmann M, Becker HD. Bronchoscopic long-term palliation of a recurrent atypical carcinoid tumor. Respiration 2011; 81 (4) 345-350
• 20 Fuks L, Fruchter O, Amital A, Fox BD, Abdel Rahman N, Kramer MR. Long-term follow-up of flexible bronchoscopic treatment for bronchial carcinoids with curative intent. Diagn Ther Endosc 2009; 2009: 782961
• 21 Neyman K, Sundset A, Naalsund A , et al. Endoscopic treatment of bronchial carcinoids in comparison to surgical resection: a retrospective study. J Bronchology Interv Pulmonol 2012; 19 (1) 29-34
• 22 Lococo F, Cesario A, Paci M , et al. PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids. Tumour Biol 2014; 35 (9) 8369-8377
• 23 Venkitaraman B, Karunanithi S, Kumar A, Khilnani GC, Kumar R. Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid. Eur J Nucl Med Mol Imaging 2014; 41 (5) 856-864
• 24 Douek PC, Simoni L, Revel D, Cordier JF, Amiel M. Diagnosis of bronchial carcinoid tumor by ultrafast contrast-enhanced MR imaging. AJR Am J Roentgenol 1994; 163 (3) 563-564
• 25 Bostanci K, Solano JR, Becker HD. Is there a role of EBUS in the decision-making of endoscopic treatment for carcinoid tumors?. Eur Respir J 2011; 38 (55) 231
• 26 Phan AT, Oberg K, Choi J , et al; North American Neuroendocrine Tumor Society (NANETS). NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus). Pancreas 2010; 39 (6) 784-798
• 27 Luckraz H, Amer K, Thomas L, Gibbs A, Butchart EG. Long-term outcome of bronchoscopically resected endobronchial typical carcinoid tumors. J Thorac Cardiovasc Surg 2006; 132 (1) 113-115
• 28 Cavaliere S, Foccoli P, Toninelli C. Curative bronchoscopic laser therapy for surgically resectable tracheobronchial tumors: personal experience. Journal of Bronchology 2002; 9 (2) 90-95